Atlas Venture Associates IX’s Spero Therapeutics SPRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | $1.64M | Hold |
1,353,303
| – | – | 13.93% | 3 |
|
|
2023
Q2 | $1.96M | Sell |
1,353,303
-23,665
| -2% | -$34.3K | 10.74% | 3 |
|
|
2023
Q1 | $2M | Hold |
1,376,968
| – | – | 9.37% | 3 |
|
|
2022
Q4 | $2.38M | Hold |
1,376,968
| – | – | 11.85% | 3 |
|
|
2022
Q3 | $2.75M | Hold |
1,376,968
| – | – | 8.16% | 3 |
|
|
2022
Q2 | $1.02M | Hold |
1,376,968
| – | – | 2.32% | 6 |
|
|
2022
Q1 | $12M | Hold |
1,376,968
| – | – | 11.02% | 2 |
|
|
2021
Q4 | $22M | Hold |
1,376,968
| – | – | 9.62% | 2 |
|
|
2021
Q3 | $25.4M | Hold |
1,376,968
| – | – | 8.43% | 2 |
|
|
2021
Q2 | $19.2M | Hold |
1,376,968
| – | – | 3.38% | 3 |
|
|
2021
Q1 | $20.3M | Hold |
1,376,968
| – | – | 3.41% | 4 |
|
|
2020
Q4 | $26.7M | Hold |
1,376,968
| – | – | 4.23% | 4 |
|
|
2020
Q3 | $15.4M | Hold |
1,376,968
| – | – | 15.9% | 3 |
|
|
2020
Q2 | $18.6M | Hold |
1,376,968
| – | – | 19.92% | 3 |
|
|
2020
Q1 | $11.1M | Hold |
1,376,968
| – | – | 23.53% | 2 |
|
|
2019
Q4 | $13.2M | Hold |
1,376,968
| – | – | 23.08% | 2 |
|
|
2019
Q3 | $14.6M | Hold |
1,376,968
| – | – | 24.02% | 2 |
|
|
2019
Q2 | $15.8M | Hold |
1,376,968
| – | – | 16.95% | 3 |
|
|
2019
Q1 | $17.6M | Hold |
1,376,968
| – | – | 16.57% | 4 |
|
|
2018
Q4 | $8.47M | Hold |
1,376,968
| – | – | 9.75% | 5 |
|
|
2018
Q3 | $14.5M | Hold |
1,376,968
| – | – | 7.66% | 5 |
|
|
2018
Q2 | $20.2M | Hold |
1,376,968
| – | – | 8.89% | 5 |
|
|
2018
Q1 | $19.6M | Hold |
1,376,968
| – | – | 14.83% | 4 |
|
|
2017
Q4 | $16.2M | Buy |
+1,376,968
| New | +$16.2M | 14.33% | 3 |
|